Efficacy and tolerability of felodipine based antihypertensive therapy in hospitalized patients with hypertension. Kotovskaia, I., V., Bagmanova, N., K., Mil'to, A., S., Riabova, A., V., Plavunov, N., F., & Kobalava, Z., D. Kardiologiia, 44(3):47-51, 2004. Website abstract bibtex AIM: To compare efficacy and tolerability of felodipine based antihypertensive therapy with those of standard hospital treatment of hypertension. MATERIAL: Inhospital patients were randomized 1:2 to standard antihypertensive therapy or to therapy which included felodipine (n=50 and 100, 36 and 35% men, mean age 66.0+/-8.4 and 64.3+/-8.1 years, initial blood pressure 162.4+/-9.3/99.3+/-6.4 and 163.2+/-10.3/98.2+/-6.5 mm Hg, respectively). Felodipine was used: (1) as first drug with subsequent addition of other drugs as required; (2) after cessation of previously ineffective therapy; (3) in cases of intolerance to previous therapy, (4) as supplementation to previously insufficiently effective therapy. Results. At discharge in felodipine group 6, 25, 29 and 40% of patients received mono- (felodipine 10 mg/day), 2, 3 and 4 component therapy, respectively. In standard treatment group all patients received combination therapy with 3 (48%) or 4 (52%) drugs. Felodipine group compared with group of standard therapy was characterized by less frequent correction of antihypertensive therapy (0.8+/-0.6 and 2.2+/-0.9, p<0.05), smaller number of drugs used (3.03+/-0.95 and 3.52+/-0.5, p<0.01), more frequently achievement of target blood pressure level (88 and 64%, p=0.0075), less pronounced difference between morning and evening self-measured blood pressure. CONCLUSION: The use of felodipine in hospitalized patients with hypertension allowed achieving target blood pressure with fewer drugs. Felodipine was safe and well tolerated.
@article{
title = {Efficacy and tolerability of felodipine based antihypertensive therapy in hospitalized patients with hypertension},
type = {article},
year = {2004},
identifiers = {[object Object]},
keywords = {Aged,Antihypertensive Agents,Calcium Channel Blockers,Combination,Drug Therapy,Felodipine,Female,Humans,Hypertension,Inpatients,Male,Middle Aged,Safety,Time Factors,Treatment Outcome},
pages = {47-51},
volume = {44},
websites = {https://elibrary.ru/item.asp?id=17063460,http://www.ncbi.nlm.nih.gov/pubmed/15489847},
id = {a52daaf2-139a-3dd1-9b42-0b4826c4f29a},
created = {2020-09-03T09:55:36.340Z},
file_attached = {false},
profile_id = {8f80f9b8-2860-34d1-8129-337101945313},
last_modified = {2020-09-18T18:53:09.666Z},
read = {false},
starred = {true},
authored = {true},
confirmed = {false},
hidden = {false},
folder_uuids = {3b6b3a51-3f12-405a-8390-afeab6608253,10cb8021-9e10-468e-b14d-4a626ad4a213},
private_publication = {false},
abstract = {AIM: To compare efficacy and tolerability of felodipine based antihypertensive therapy with those of standard hospital treatment of hypertension. MATERIAL: Inhospital patients were randomized 1:2 to standard antihypertensive therapy or to therapy which included felodipine (n=50 and 100, 36 and 35% men, mean age 66.0+/-8.4 and 64.3+/-8.1 years, initial blood pressure 162.4+/-9.3/99.3+/-6.4 and 163.2+/-10.3/98.2+/-6.5 mm Hg, respectively). Felodipine was used: (1) as first drug with subsequent addition of other drugs as required; (2) after cessation of previously ineffective therapy; (3) in cases of intolerance to previous therapy, (4) as supplementation to previously insufficiently effective therapy. Results. At discharge in felodipine group 6, 25, 29 and 40% of patients received mono- (felodipine 10 mg/day), 2, 3 and 4 component therapy, respectively. In standard treatment group all patients received combination therapy with 3 (48%) or 4 (52%) drugs. Felodipine group compared with group of standard therapy was characterized by less frequent correction of antihypertensive therapy (0.8+/-0.6 and 2.2+/-0.9, p<0.05), smaller number of drugs used (3.03+/-0.95 and 3.52+/-0.5, p<0.01), more frequently achievement of target blood pressure level (88 and 64%, p=0.0075), less pronounced difference between morning and evening self-measured blood pressure. CONCLUSION: The use of felodipine in hospitalized patients with hypertension allowed achieving target blood pressure with fewer drugs. Felodipine was safe and well tolerated.},
bibtype = {article},
author = {Kotovskaia, Iu V. and Bagmanova, N. Kh and Mil'to, A. S. and Riabova, A. V. and Plavunov, N. F. and Kobalava, Zh D.},
journal = {Kardiologiia},
number = {3}
}
Downloads: 0
{"_id":"qCZ5j7nqPLWL7BJZR","bibbaseid":"kotovskaia-bagmanova-milto-riabova-plavunov-kobalava-efficacyandtolerabilityoffelodipinebasedantihypertensivetherapyinhospitalizedpatientswithhypertension-2004","authorIDs":["SNEJn8MPgXBDujBuL"],"author_short":["Kotovskaia, I., V.","Bagmanova, N., K.","Mil'to, A., S.","Riabova, A., V.","Plavunov, N., F.","Kobalava, Z., D."],"bibdata":{"title":"Efficacy and tolerability of felodipine based antihypertensive therapy in hospitalized patients with hypertension","type":"article","year":"2004","identifiers":"[object Object]","keywords":"Aged,Antihypertensive Agents,Calcium Channel Blockers,Combination,Drug Therapy,Felodipine,Female,Humans,Hypertension,Inpatients,Male,Middle Aged,Safety,Time Factors,Treatment Outcome","pages":"47-51","volume":"44","websites":"https://elibrary.ru/item.asp?id=17063460,http://www.ncbi.nlm.nih.gov/pubmed/15489847","id":"a52daaf2-139a-3dd1-9b42-0b4826c4f29a","created":"2020-09-03T09:55:36.340Z","file_attached":false,"profile_id":"8f80f9b8-2860-34d1-8129-337101945313","last_modified":"2020-09-18T18:53:09.666Z","read":false,"starred":"true","authored":"true","confirmed":false,"hidden":false,"folder_uuids":"3b6b3a51-3f12-405a-8390-afeab6608253,10cb8021-9e10-468e-b14d-4a626ad4a213","private_publication":false,"abstract":"AIM: To compare efficacy and tolerability of felodipine based antihypertensive therapy with those of standard hospital treatment of hypertension. MATERIAL: Inhospital patients were randomized 1:2 to standard antihypertensive therapy or to therapy which included felodipine (n=50 and 100, 36 and 35% men, mean age 66.0+/-8.4 and 64.3+/-8.1 years, initial blood pressure 162.4+/-9.3/99.3+/-6.4 and 163.2+/-10.3/98.2+/-6.5 mm Hg, respectively). Felodipine was used: (1) as first drug with subsequent addition of other drugs as required; (2) after cessation of previously ineffective therapy; (3) in cases of intolerance to previous therapy, (4) as supplementation to previously insufficiently effective therapy. Results. At discharge in felodipine group 6, 25, 29 and 40% of patients received mono- (felodipine 10 mg/day), 2, 3 and 4 component therapy, respectively. In standard treatment group all patients received combination therapy with 3 (48%) or 4 (52%) drugs. Felodipine group compared with group of standard therapy was characterized by less frequent correction of antihypertensive therapy (0.8+/-0.6 and 2.2+/-0.9, p<0.05), smaller number of drugs used (3.03+/-0.95 and 3.52+/-0.5, p<0.01), more frequently achievement of target blood pressure level (88 and 64%, p=0.0075), less pronounced difference between morning and evening self-measured blood pressure. CONCLUSION: The use of felodipine in hospitalized patients with hypertension allowed achieving target blood pressure with fewer drugs. Felodipine was safe and well tolerated.","bibtype":"article","author":"Kotovskaia, Iu V. and Bagmanova, N. Kh and Mil'to, A. S. and Riabova, A. V. and Plavunov, N. F. and Kobalava, Zh D.","journal":"Kardiologiia","number":"3","bibtex":"@article{\n title = {Efficacy and tolerability of felodipine based antihypertensive therapy in hospitalized patients with hypertension},\n type = {article},\n year = {2004},\n identifiers = {[object Object]},\n keywords = {Aged,Antihypertensive Agents,Calcium Channel Blockers,Combination,Drug Therapy,Felodipine,Female,Humans,Hypertension,Inpatients,Male,Middle Aged,Safety,Time Factors,Treatment Outcome},\n pages = {47-51},\n volume = {44},\n websites = {https://elibrary.ru/item.asp?id=17063460,http://www.ncbi.nlm.nih.gov/pubmed/15489847},\n id = {a52daaf2-139a-3dd1-9b42-0b4826c4f29a},\n created = {2020-09-03T09:55:36.340Z},\n file_attached = {false},\n profile_id = {8f80f9b8-2860-34d1-8129-337101945313},\n last_modified = {2020-09-18T18:53:09.666Z},\n read = {false},\n starred = {true},\n authored = {true},\n confirmed = {false},\n hidden = {false},\n folder_uuids = {3b6b3a51-3f12-405a-8390-afeab6608253,10cb8021-9e10-468e-b14d-4a626ad4a213},\n private_publication = {false},\n abstract = {AIM: To compare efficacy and tolerability of felodipine based antihypertensive therapy with those of standard hospital treatment of hypertension. MATERIAL: Inhospital patients were randomized 1:2 to standard antihypertensive therapy or to therapy which included felodipine (n=50 and 100, 36 and 35% men, mean age 66.0+/-8.4 and 64.3+/-8.1 years, initial blood pressure 162.4+/-9.3/99.3+/-6.4 and 163.2+/-10.3/98.2+/-6.5 mm Hg, respectively). Felodipine was used: (1) as first drug with subsequent addition of other drugs as required; (2) after cessation of previously ineffective therapy; (3) in cases of intolerance to previous therapy, (4) as supplementation to previously insufficiently effective therapy. Results. At discharge in felodipine group 6, 25, 29 and 40% of patients received mono- (felodipine 10 mg/day), 2, 3 and 4 component therapy, respectively. In standard treatment group all patients received combination therapy with 3 (48%) or 4 (52%) drugs. Felodipine group compared with group of standard therapy was characterized by less frequent correction of antihypertensive therapy (0.8+/-0.6 and 2.2+/-0.9, p<0.05), smaller number of drugs used (3.03+/-0.95 and 3.52+/-0.5, p<0.01), more frequently achievement of target blood pressure level (88 and 64%, p=0.0075), less pronounced difference between morning and evening self-measured blood pressure. CONCLUSION: The use of felodipine in hospitalized patients with hypertension allowed achieving target blood pressure with fewer drugs. Felodipine was safe and well tolerated.},\n bibtype = {article},\n author = {Kotovskaia, Iu V. and Bagmanova, N. Kh and Mil'to, A. S. and Riabova, A. V. and Plavunov, N. F. and Kobalava, Zh D.},\n journal = {Kardiologiia},\n number = {3}\n}","author_short":["Kotovskaia, I., V.","Bagmanova, N., K.","Mil'to, A., S.","Riabova, A., V.","Plavunov, N., F.","Kobalava, Z., D."],"urls":{"Website":"https://elibrary.ru/item.asp?id=17063460,http://www.ncbi.nlm.nih.gov/pubmed/15489847"},"bibbaseid":"kotovskaia-bagmanova-milto-riabova-plavunov-kobalava-efficacyandtolerabilityoffelodipinebasedantihypertensivetherapyinhospitalizedpatientswithhypertension-2004","role":"author","keyword":["Aged","Antihypertensive Agents","Calcium Channel Blockers","Combination","Drug Therapy","Felodipine","Female","Humans","Hypertension","Inpatients","Male","Middle Aged","Safety","Time Factors","Treatment Outcome"],"downloads":0},"bibtype":"article","creationDate":"2020-09-19T11:07:54.421Z","downloads":0,"keywords":["aged","antihypertensive agents","calcium channel blockers","combination","drug therapy","felodipine","female","humans","hypertension","inpatients","male","middle aged","safety","time factors","treatment outcome"],"search_terms":["efficacy","tolerability","felodipine","based","antihypertensive","therapy","hospitalized","patients","hypertension","kotovskaia","bagmanova","mil'to","riabova","plavunov","kobalava"],"title":"Efficacy and tolerability of felodipine based antihypertensive therapy in hospitalized patients with hypertension","year":2004}